Dyslipidemia in Cardiovascular Disease

NCT01029522 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

244

Enrollment

INDUSTRY

Sponsor class

Conditions

Dyslipidemia

Interventions

DRUG: Atorvastatin (Lipilou)
DRUG: Atorvastatin (Lipitor)

Sponsor

Chong Kun Dang Pharmaceutical